NewYork-Presbyterian Hospital Switches to Global Med's Transfusion Software System
August 05 2005 - 9:00AM
PR Newswire (US)
SafeTrace Tx(R) Selected by Prestigious New York City University
Hospital DENVER, Aug. 5 /PRNewswire-FirstCall/ --
NewYork-Presbyterian Hospital, one of the most prestigious medical
centers in the world, has purchased SafeTrace Tx(R)* from Wyndgate
Technologies(R), a division of Global Med Technologies(R), Inc.
(OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med" or the "Company").
The advanced transfusion management system will be used at its
NewYork-Presbyterian/Columbia and NewYork-Presbyterian/Allen
Pavilion sites. Terms of the agreement were not disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Henri
Thomas, Manager, AIS for NewYork-Presbyterian Hospital/Columbia
University Medical Center, stated, "Wyndgate has successfully
developed software to manage the complexities of our transfusion
service business. We selected SafeTrace Tx for its comprehensive
safety features and application capabilities, which will facilitate
our vision of NewYork-Presbyterian's future." Mr. Thomas continued,
"Other factors influencing our decision to purchase SafeTrace Tx
were Wyndgate's market experience, reputation, application
functionality, product lifecycle, implementation experience,
product support and commitment to our future." Thomas F. Marcinek,
President and COO of Global Med Technologies, Inc., stated, "We are
delighted that NewYork-Presbyterian Hospital now joins the
migration of many leading health care institutions to our products
and services. Wyndgate supports NewYork-Presbyterian's purchase
with our quality staff, reputation for service, commitment to
excellence and high technological standards that are known to the
industry." Mr. Marcinek added, "We believe this significant
business agreement with NewYork-Presbyterian Hospital underscores
our commitment to quality and safety in helping health care
facilities of all sizes and levels of complexity efficiently manage
transfusion operations." About NewYork-Presbyterian Hospital
NewYork-Presbyterian Hospital -- based in New York City -- is the
largest not-for-profit, non-sectarian hospital in the country, with
2,397 beds. It provides state-of-the-art inpatient, ambulatory, and
preventive care in all areas of medicine at five major centers:
NewYork-Presbyterian Hospital/Weill Cornell Medical Center,
NewYork-Presbyterian Hospital/Columbia University Medical Center,
Morgan Stanley Children's Hospital of NewYork-Presbyterian,
NewYork-Presbyterian Hospital/Allen Pavilion, and
NewYork-Presbyterian Hospital/Westchester Division. One of the
largest and most comprehensive health-care institutions in the
world, the Hospital is committed to excellence in patient care,
research, education, and community service. It consistently ranks
as one of the top hospitals in the country in U.S. News & World
Report's guide to "America's Best Hospitals, in New York magazine's
Best Doctors issue, in Solucient's top 15 major teaching hospitals,
and in many other leading surveys. The Hospital has academic
affiliations with two of the country's leading medical colleges:
Joan and Sanford I. Weill Medical College of Cornell University,
and Columbia University College of Physicians & Surgeons. About
Global Med Technologies, Inc. Global Med Technologies, Inc. is an
international e-Health, medical information technology company,
providing information management software products and services to
the healthcare industry. Its Wyndgate Technologies division is a
leading supplier of information management systems to U.S. and
international blood centers and hospital transfusion centers.
Current clients of Wyndgate's products and services manage more
than 3 million units of blood, or over 22% of the U.S. blood
supply, each year. Wyndgate's products are also being implemented
in Canada, the Caribbean and sub-Sahara Africa. Together, the
SafeTrace Tx advanced transfusion management system and the
SafeTrace(R) donor management system provide Vein-to-Vein(R)
tracking from donor collection to patient transfusion. For more
information about Global Med's products and services, please call
800-WYNDGATE or visit http://www.globalmedtech.com/,
http://www.peoplemed.com/ and http://www.wyndgate.com/. This news
release may include statements that constitute forward-looking
statements, usually containing the words "believe," "estimate,"
"project," "expects" or similar expressions. These statements are
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements inherently involve risks and uncertainties that could
cause actual results to differ materially from the forward-looking
statements. By making these forward-looking statements, the Company
undertakes no obligation to update these statements for revisions
or changes after the date of this news release. * Patent Pending
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies(R),
Inc., +1-303-238-2000; or Investor Relations, John Nesbett, or
Jordan Silverstein both of The Investor Relations Group,
+1-212-825-3210, for Global Med Technologies, Inc. Web site:
http://www.wyndgate.com/ Web site: http://www.peoplemed.com/ Web
site: http://www.globalmedtech.com/
Copyright